Prado Arturo, Andrades Patricio, Leniz Patricio
Division of Plastic Surgery, School of Medicine, Clinical Hospital JJ Aguirre, University of Chile, Chile.
Aesthetic Plast Surg. 2007 Jul-Aug;31(4):317-9. doi: 10.1007/s00266-006-0131-7.
After the "fifth-generation" breast implants with ultracohesive silicone gel technology are introduced, the Food and Drug Administration (FDA) will sooner or later retire the ban on the use of these devices in the United States. When this happens, the plastic surgery community must be prepared to face a massive demand for reoperations to change saline-filled breast implants because cohesive gel devices have the potential to provide a more natural breast shape, to minimize the risk of postoperative rippling, and to provide a greater degree of safety if the implant loses its integrity. Despite these advantages and extensive use throughout the rest of the world during the ban in the United States, silicone implants also have disadvantages. One drawback is that transaxillary breast augmentation with more "rigid" gel-filled implants may produce trauma to the armpit, may interfere with sentinel node mapping for breast cancer treatment, and may have future medicolegal implications.
随着采用超粘性硅胶凝胶技术的“第五代”乳房植入物问世，美国食品药品监督管理局（FDA）迟早会取消在美国使用这些器械的禁令。届时，整形外科学界必须做好准备，迎接大量更换盐水填充乳房植入物的再次手术需求，因为粘性凝胶器械有可能塑造出更自然的乳房形状，将术后波纹风险降至最低，并且在植入物完整性受损时提供更高的安全性。尽管在美国禁令期间这些植入物在世界其他地区得到广泛使用且具有这些优点，但硅胶植入物也存在缺点。一个缺点是，使用更“硬”的凝胶填充植入物进行经腋窝隆胸可能会对腋窝造成创伤，可能会干扰乳腺癌治疗中的前哨淋巴结定位，并且可能会带来未来的法医学问题。
